Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Measuring the sweet smell of success in diabetes management.

Literature DB >> 25568872

Measuring the sweet smell of success in diabetes management.

Jeff Unger¹.

Abstract

Entities: Disease

Year: 2014 PMID： 25568872 PMCID： PMC4260044 DOI： 10.3978/j.issn.2305-5839.2014.08.04

Source DB: PubMed Journal: Ann Transl Med ISSN： 2305-5839

Keyword Cloud
References

× No keyword cloud information.

11 in total

1. LONGEVITY AND MORTALITY OF DIABETICS.

Authors: H H MARKS
Journal: Am J Public Health Nations Health Date: 1965-03

2. High risk of cardiovascular mortality in individuals with impaired fasting glucose is explained by conversion to diabetes: the Hoorn study.

Authors: Josina M Rijkelijkhuizen; Giel Nijpels; Robert J Heine; Lex M Bouter; Coen D A Stehouwer; Jacqueline M Dekker
Journal: Diabetes Care Date: 2007-02 Impact factor: 19.112

3. Diagnosis and management of prediabetes in the continuum of hyperglycemia: when do the risks of diabetes begin? A consensus statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Authors: Alan J Garber; Yehuda Handelsman; Daniel Einhorn; Donald A Bergman; Zachary T Bloomgarden; Vivian Fonseca; W Timothy Garvey; James R Gavin; George Grunberger; Edward S Horton; Paul S Jellinger; Kenneth L Jones; Harold Lebovitz; Philip Levy; Darren K McGuire; Etie S Moghissi; Richard W Nesto
Journal: Endocr Pract Date: 2008-10 Impact factor: 3.443

Measuring the sweet smell of success in diabetes management.

1. LONGEVITY AND MORTALITY OF DIABETICS.

2. High risk of cardiovascular mortality in individuals with impaired fasting glucose is explained by conversion to diabetes: the Hoorn study.

3. Diagnosis and management of prediabetes in the continuum of hyperglycemia: when do the risks of diabetes begin? A consensus statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists.

4. Costs of screening for pre-diabetes among US adults: a comparison of different screening strategies.

5. Standards of medical care in diabetes--2014.

6. Diabetes mellitus. A review of mortality experience.

7. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

8. Changes in diabetes-related complications in the United States, 1990-2010.

9. Cost-effectiveness of screening for pre-diabetes among overweight and obese U.S. adults.

10. Regression from pre-diabetes to normal glucose regulation in the diabetes prevention program.